Literature DB >> 26022143

Evaluation of larval density Cochliomyia macellaria F. (Diptera: Calliphoridae) for therapeutic use in the recovery of tegumentar injuries.

Mariana Prado Nassu1, Patricia Jacqueline Thyssen.   

Abstract

Larval therapy (LT) is the application of carrion flies (Diptera) sterile larvae on chronic or infected wounds to promote or accelerate the healing process. High cost and the development of resistance by certain groups of pathogenic bacteria to these drugs encouraged the resurgence of LT, currently used in approximately 20 countries and more recently in Brazil. This study evaluated the behavior and larval density of Cochliomyia macellaria F. (Calliphoridae), one of the most appropriate species for debridement of injuries with necrotic tissue. Tegumentar lesions were induced in Wistar rats by subcutaneously application of 0.2 ml of a 1:4 hydrochloric acid and sterile distilled water in the dorsal region. Five experimental groups were set up: (LT 5) treatment with 5 larvae/cm(2); (LT 15) 15 larvae/cm(2); (LT 25) 25 larvae/cm(2); (DEB) mechanical debridement, and (NUL) animals that did not receive any treatment. In the LT groups, larvae used were sterilized with sodium hypochlorite (NaClO) and maintained for 12 h in the lesions. The healing process was assessed qualitatively (macroscopically and microscopically) and quantitatively (time interval to complete healing). It was observed that the immature fed only on necrotic tissue, thus C. macellaria is an excellent candidate for use in LT. There was no significant difference in healing time between experimental groups. However, it was observed that in LT 25, there was greater vascularization in tissues when compared to the other treatments. The mechanisms involved in this process are unknown, but it is evident that the larvae have an important role in modulating the host immune response. It is essential that future applications of larval therapy consider using a higher density of larvae (minimum of 25 larvae/cm(2)) than is currently recommended.

Entities:  

Mesh:

Year:  2015        PMID: 26022143     DOI: 10.1007/s00436-015-4542-8

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  18 in total

1.  Maggot therapy for treating diabetic foot ulcers unresponsive to conventional therapy.

Authors:  Ronald A Sherman
Journal:  Diabetes Care       Date:  2003-02       Impact factor: 19.112

2.  Life cycle and attacks of ectoparasites on ruminants during the year in Central Europe: recommendations for treatment with insecticides (e.g., Butox).

Authors:  Heinz Mehlhorn; Khaled A S Al-Rasheid; Fathy Abdel-Ghaffar; Sven Klimpel; Herbert Pohle
Journal:  Parasitol Res       Date:  2010-06-22       Impact factor: 2.289

3.  A Bactericidal Principle in Excretions of Surgical Maggots which Destroys Important Etiological Agents of Pyogenic Infections.

Authors:  S W Simmons
Journal:  J Bacteriol       Date:  1935-09       Impact factor: 3.490

4.  Maggot therapy for subacute mastoiditis.

Authors:  K L Horn; A H Cobb; G A Gates
Journal:  Arch Otolaryngol       Date:  1976-06

5.  Two different myiasis cases in southeast of Turkey: ophthalmomyiasis and cutaneous myiasis.

Authors:  Mehmet Dokur; Fadime Eroglu; Duygu Neval Sayın Ipek; Nilgün Ulutasdemir
Journal:  Parasitol Res       Date:  2015-04-07       Impact factor: 2.289

6.  Histological patterns in healing chronic wounds using Cochliomyia macellaria (Diptera: Calliphoridae) larvae and other therapeutic measures.

Authors:  Franciéle Souza de Masiero; Mariana Prado Nassu; Mauro Pereira Soares; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2015-04-24       Impact factor: 2.289

7.  Wound debridement potential of glycosidases of the wound-healing maggot, Lucilia sericata.

Authors:  G Telford; A P Brown; A Rich; J S C English; D I Pritchard
Journal:  Med Vet Entomol       Date:  2012-05-24       Impact factor: 2.739

8.  Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses.

Authors:  Mariena J A van der Plas; Anne M van der Does; Mara Baldry; Heleen C M Dogterom-Ballering; Co van Gulpen; Jaap T van Dissel; Peter H Nibbering; Gerrolt N Jukema
Journal:  Microbes Infect       Date:  2007-01-27       Impact factor: 2.700

9.  Maggot therapy for treating pressure ulcers in spinal cord injury patients.

Authors:  R A Sherman; F Wyle; M Vulpe
Journal:  J Spinal Cord Med       Date:  1995-04       Impact factor: 1.985

10.  Fatty acid extracts from Lucilia sericata larvae promote murine cutaneous wound healing by angiogenic activity.

Authors:  Zhen Zhang; Shouyu Wang; Yunpeng Diao; Jianing Zhang; Decheng Lv
Journal:  Lipids Health Dis       Date:  2010-03-08       Impact factor: 3.876

View more
  3 in total

1.  Life History of Cochliomyia macellaria (Fabricius, 1775) (Diptera, Calliphoridae), a Blowfly of Medical and Forensic Importance.

Authors:  D M Alvarez Garcia; A Pérez-Hérazo; E Amat
Journal:  Neotrop Entomol       Date:  2017-03-06       Impact factor: 1.434

2.  Evaluation of conventional therapeutic methods versus maggot therapy in the evolution of healing of tegumental injuries in Wistar rats with and without diabetes mellitus.

Authors:  Franciéle Souza Masiero; Patricia Jacqueline Thyssen
Journal:  Parasitol Res       Date:  2016-03-15       Impact factor: 2.289

3.  First Record of Larval Secretions of Cochliomyia macellaria (Fabricius, 1775) (Diptera: Calliphoridae) Inhibiting the Growth of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  F S Masiero; M F K Aquino; M P Nassu; D I B Pereira; D S Leite; P J Thyssen
Journal:  Neotrop Entomol       Date:  2016-10-01       Impact factor: 1.434

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.